Staff editor
The race toward evidence-based microbiome nutrition has just found its new headquarters.
The company is now taking a decisive step from laboratory-scale research to industrial-scale biofermentation.
Professor Alessandro Gramenzi discusses the current knowledge of the gut microbiota in companion animals and the opportunities to modulate it through nutritional interventions.
Industry, Neuroscience
Sponsored by
A study demonstrates that synbiotic supplementation, alone or combined with GDH, is a safe and effective adjunct therapy for autistic children with DGBI.
The combination of biological innovation and pharmaceutical muscle could create a unique pathway for translating microbiome discoveries into accessible, science-backed solutions for everyday health.
The gut microbiome has emerged not just as a passive bystander in sports, but as an active modulator of athletic energy, recovery, and resilience.
New funding boosts development of microbiome-based therapies for hereditary cancer risk, opening paths to alternatives beyond surgery.
The Bill & Melinda Gates Foundation accelerates research and innovation targeting the most neglected areas of female health.
With a strategic loan from the European Investment Bank, the French biotech doubles down on its mission to bring microbiome ecosystem therapies to market for patients battling blood cancers.
Professor Ruggiero Francavilla, pediatric gastroenterologist at the Polyclinic of Bari (Italy), offers a preview of his upcoming talk at the 10th International Congress of Probiotics, Prebiotics, and Postbiotics in Pediatrics.
